Actively Recruiting
Evidence Development in Cancer Treatment - Real World: PREDiCTrw
Led by British Columbia Cancer Agency · Updated on 2025-09-25
100
Participants Needed
1
Research Sites
258 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This pilot clinical trial aims to assess the real world quality of life and survival of patients treated with therapy that has preliminary evidence of efficacy but uncertainty of the magnitude of clinical benefit or cost effectiveness in subjects with cancer. The goal of this study is to collect real world evidence with respect to quality of life and outcomes to support decision making.
CONDITIONS
Official Title
Evidence Development in Cancer Treatment - Real World: PREDiCTrw
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subjects with cancer for which there remains ongoing questions regarding clinical effectiveness and/or cost effectiveness regarding a therapeutic agent
- Eastern Co-operative Group (ECOG) 0-2
- Life expectancy of at least 12 weeks
- Adequate hematologic and end organ function for drug treatment per the clinician's assessment
- Asymptomatic or treated brain metastases permitted
- For women of childbearing potential: agreement to remain abstinent or use contraceptive methods with failure rate less than 1% per year during treatment and for 5 months after last dose
- For men: agreement to remain abstinent or use contraceptive measures and refrain from donating sperm during treatment and for 5 months after last dose
- Ability to give informed consent for the study procedures
You will not qualify if you...
- Treatment with any approved or investigational agent or participation in another clinical trial with therapeutic intent within 14 days prior to enrollment
- Inability to complete quality of life questionnaires
- Pregnancy or breastfeeding
- Significant cardiovascular disease, comorbidity, or major surgery within 21 days considered unsafe by investigator
- Subjects considered unfit by treating clinician to proceed with this protocol
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
BC Cancer
Vancouver, British Columbia, Canada, V5Z4E6
Actively Recruiting
Research Team
C
Cheryl Ho, MD
CONTACT
H
Howard Lim, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here